TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Astimex Pharma AB
Closing information (x1000 NOK)
| Closing information | 2024/06 | 2023/06 | 2022/06 |
| Turnover |
73,424
|
52,931
|
38,711 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
33,412
|
19,076
|
10,918 |
| EBITDA |
32,014
|
18,468
|
10,978 |
| Total assets |
52,750
|
64,615
|
51,312 |
| Current assets |
52,631
|
64,346
|
51,113 |
| Current liabilities |
11,068
|
7,779
|
7,472 |
| Equity capital |
38,416
|
53,612
|
41,734 |
| - share capital |
100
|
99
|
97 |
| Employees (average) |
6
|
6
|
6 |
Financial ratios
| Fiscal year | 2024/06 | 2023/06 | 2022/06 |
| Solvency |
72.8%
|
83.0%
|
81.3% |
| Turnover per employee |
12,237
|
8,822
|
6,452 |
| Profit as a percentage of turnover |
45.5%
|
36.0%
|
28.2% |
| Return on assets (ROA) |
63.3%
|
29.5%
|
21.3% |
| Current ratio |
475.5%
|
827.2%
|
684.1% |
| Return on equity (ROE) |
87.0%
|
35.6%
|
26.2% |
| Change turnover |
19,808
|
13,385
|
1,489 |
| Change turnover % |
37%
|
34%
|
4% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/06 | 2023/06 | 2022/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.